Manual práctico de Trombosis y Hemostasia de la SETH

— 1 8 1 — 1 . M e d i c i n a c a r d i o v a s c u l a r ARTERIOPATÍA PERIFÉRICA Los pacientes con arteriopatía periférica sintomática se be- nefician de la terapia antiplaquetaria con AAS (100 mg/día) o clopidogrel (75 mg/día). No está indicada la doble antiagrega- ción ni la anticoagulación. En caso de embolismo arterial periférico de origen cardia- co (por ejemplo FA), sí estaría indicada la anticoagulación oral, pero no se recomienda la doble terapia antitrombótica, esto es antiagregación junto anticoagulación (16). BIBLIOGRAFÍA 1. Instituto Nacional de Estadística. http://www.ine.es/dynt3/ineba- se/index.htm?type=pcaxis&path=/t15/p417/a2014/&file=pcaxis 2. Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 2014;276:618-32. 3. De Caterina R, Husted S,Wallentin L, Andreotti F, Arnesen H, Ba- chmann F, et al.; European Society of CardiologyWorking Group on Thrombosis Task Force on Anticoagulants in Heart Disease. General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESCWorking Group onThrom- bosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013;109:569-79. 4. Roffi M, Patrono C, Collet JP, Mueller C,Valgimigli M, Andreotti F, et al.; Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the Eu- ropean Society of Cardiology. 2015 ESC Guidelines for the ma- nagement of acute coronary syndromes in patients presenting without persistent ST-segment elevation:Task Force for the Ma- nagement of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315. 5. Comentarios a la guia ESC 2015 sobre el tratamiento de los sin- dromes coronarios agudos en pacientes sin elevacion persistente del segmento ST. Grupo de Trabajo de la SEC para la guia ESC 2015 sobre el tratamiento de los sindromes coronarios agudos en pacientes sin elevacion persistente del segmento ST, revisores expertos para la guia ESC 2015 sobre el tratamiento de los sin- dromes coronarios agudos en pacientes sin elevacion persistente del segmento ST y Comite de Guias de la SEC. Rev Esp Cardiol 2015;68:1061-7. 6. Lip GY,Windecker S, Huber K, Kirchhof P, Marin F,Ten Berg JM, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing per- cutaneous coronary or valve interventions: a joint consensus do- cument of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), Eu- ropean Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 2014;35:3155-79. 7. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al.; Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intra- venous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929-35. 8. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaer- schalk BM, et al.; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vas- cular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a gui- deline for healthcare professionals from the American Heart As- sociation/American Stroke Association. Stroke 2013;44:870-947. 9. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al.; American Heart Association Stroke Coun- cil, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare profes- sionals from the American Heart Association/American Stroke Association. Stroke 2014; 45:2160-236. 10. Arribas F, Roldán I, Luis Merino J, RoldánV, Arenal A,Tamargo J, et al. Comments on the 2016 ESC Guidelines for theManagement of Atrial Fibrillation. Rev Esp Cardiol (Engl Ed) 2017;70:2-8. 11. Steinberg BA. How I use anticoagulation in atrial fibrillation. Blood 2016;128:2891-8. 12. Criterios y recomendaciones generales para el uso de los anti- coagulantes orales directos (ACOD) en la prevención del ictus y la embolia sistémica en pacientes con fibrilación auricular no valvular. Ministerio de Sanidad, Servicios Sociales e Igualdad; 2016. Disponible en: https://www.aemps.gob.es/medicamentosUsoHu- mano/informesPublicos/docs/criterios-anticoagulantes-orales.pdf 13. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fi- brillation developed in collaboration with EACTS. Europace 2016;18:1609-78. 14. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. ESC Committeefor Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardio- thorac Surg 2012;42:S1-44. 15. Ponikowski P,Voors AA,Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contri- bution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891-975. 16. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corrie- re MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;69:1465-508.